Literature DB >> 8017843

Molecular interrelationships in multidrug resistance (review).

J A Kellen1.   

Abstract

A brief review of the "state of the art" (1993) knowledge concerning the interrelationships of oncogenes and tumour suppressor gene p53 in multidrug resistance is presented. Gene products which induce malignant transformation and uncontrolled proliferation may play a role in activating gene(s) involved in multidrug resistance. In view of the fact that drug resistance remains the major reason for chemotherapy failure in cancer therapy, a better understanding of the genetic connections which influence the final outcome of cancer could help rationalizing treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017843

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  The extended-MDR phenotype.

Authors:  R Davey; M Davey
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Authors:  D Byrne; C Daly; R Nicamhlaoibh; A Howlett; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

3.  Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells.

Authors:  Y Yuan; A J Tang; A B Castoreno; S-Y Kuo; Q Wang; P Kuballa; R Xavier; A F Shamji; S L Schreiber; B K Wagner
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

4.  Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy.

Authors:  J Prados; C Melguizo; J A Marchal; C Vélez; L Alvarez; A Aránega
Journal:  Jpn J Cancer Res       Date:  1999-07

5.  Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines.

Authors:  Serkan Sertel; Tolga Eichhorn; Christian H Simon; Peter K Plinkert; Steven W Johnson; Thomas Efferth
Journal:  Molecules       Date:  2010-04-22       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.